Back to Search
MARK HEINRICH, DO
DO
Family Medicine Physician
NPI: 1063467751IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
20A5375(CA)
Education
R FRANKLIN UNIVERSITY OF MED & SCI/CHICAGO MEDICAL SCHOOL
Class of 1986
Research & Publications (20)
Self-report of headache in children and adolescents in Germany: possibilities and confines of questionnaire data for headache classification.
PMID 19250286·Cephalalgia·2009
8-other
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.
PMID 18955458·J Clin Oncol·2008
3-trial
Negative ion ultraviolet matrix-assisted laser desorption ionization mass spectrometry and post source decay of glycosyl esters of nucleoside pyrophosphates.
PMID 19136728·Eur J Mass Spectrom (Chichester)·2008
8-other
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases.
PMID 18451237·Clin Cancer Res·2008
3-trial
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.
PMID 18955451·J Clin Oncol·2008
3-trial
Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.
PMID 16954519·J Clin Oncol·2006
3-trial
Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).
PMID 16505440·J Clin Oncol·2006
8-other
Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy.
PMID 15895440·J Surg Oncol·2005
6-review
Targeting mutant kinases in gastrointestinal stromal tumors: a paradigm for molecular therapy of other sarcomas.
PMID 15217222·Cancer Treat Res·2004
6-review
Targeting FLT3 kinase in acute myelogenous leukemia: progress, perils, and prospects.
PMID 15032673·Mini Rev Med Chem·2004
6-review
Is KIT an important therapeutic target in small cell lung cancer?
PMID 14676102·Clin Cancer Res·2003
8-other
Seeking support: caregiver strategies for interacting with health personnel.
PMID 14746120·Can J Nurs Res·2003
8-other
PDGFRA activating mutations in gastrointestinal stromal tumors.
PMID 12522257·Science·2003
7-preclinical
Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.
PMID 12094373·Hum Pathol·2002
6-review
Posttranscriptional cell cycle-dependent regulation of human FANCC expression.
PMID 10845936·Blood·2000
8-other
Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor.
PMID 10910906·Blood·2000
8-other
Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma.
PMID 19418217·Breast Cancer Res Treat·2010
8-other
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
PMID 18942073·J Surg Oncol·2009
3-trial
TGF-beta1 inhibits Cx43 expression and formation of functional syncytia in cultured smooth muscle cells from human detrusor.
PMID 18406048·Eur Urol·2009
8-other
Steady-state and time resolved fluorescence analysis on tyrosine-histidine model compounds.
PMID 18766301·J Fluoresc·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1611 FEATHER RIVER BLVD, SUITE 10
OROVILLE, CA 95965 - Phone
- (530) 534-4530
Quick Facts
- NPI
- 1063467751
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile